Mood Disorder
50
2
3
39
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.0%
4 terminated out of 50 trials
90.7%
+4.2% vs benchmark
4%
2 trials in Phase 3/4
15%
6 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (50)
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
Perimenopause-Related Mood and Behavioral Disorders
Study of Premenstrual Syndrome and Premenstrual Dysphoria
Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers
Effects of Postbiotics on Mood Disorders in Korean Adults
The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Dutch EASYcare Study
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
Psychiatric Co-morbidities and Socio-demographic Characteristics in Patients With Idiopathic Hypersomnia
Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal
Validation of an Automated Online Language Interpreting Tool - Phase Two.
Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model
Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders
Adolescence, Puberty, and Emotion Regulation
Assessment of Cardiac Autonomic Behavior in Patients With Mood Disorders
A Controlled Trial of Patient Centered Telepsychiatry Interventions
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
Laughter Yoga Intervention for People With Major Depressive Disorder
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)